KR850004746A - 1-페닐이미다졸리딘-2-온 유도체의 제조방법 - Google Patents

1-페닐이미다졸리딘-2-온 유도체의 제조방법 Download PDF

Info

Publication number
KR850004746A
KR850004746A KR1019840004182A KR840004182A KR850004746A KR 850004746 A KR850004746 A KR 850004746A KR 1019840004182 A KR1019840004182 A KR 1019840004182A KR 840004182 A KR840004182 A KR 840004182A KR 850004746 A KR850004746 A KR 850004746A
Authority
KR
South Korea
Prior art keywords
formula
compound
alkyl
hydrogenolysis
acid addition
Prior art date
Application number
KR1019840004182A
Other languages
English (en)
Inventor
멘트루프(외 4) 안톤
Original Assignee
베링거 인겔하임 케이지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베링거 인겔하임 케이지 filed Critical 베링거 인겔하임 케이지
Publication of KR850004746A publication Critical patent/KR850004746A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

1―페닐이미다졸리딘―2―온 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 일반식(Ⅱ)의 화합물을 일반식(Ⅲ)의 화합물과 환원성 알킬화 조건하에 반응시키고, 경우에 따라 계속해서 보호그룹을 제거하거나; 일반식(Ⅴ)의 아미노케톤을 환원시키거나; 일반식(Ⅵ)의 화합물로부터 가수소분해 또는 산성 또는 염기성 이누화에 의해 보호그룹을 제거하고; 경우에 따라, 수득된 생성물을 에난티오머로 단리시키고/시키거나, 생성물이 염기로 수득된 경우에는 산부가염으로 전환시키고, 산가부가염으로 수득된 경우에는 염기로 전환시킴을 특징으로 하여, 에난티오머의 혼합물의 형태 또는 유리에난티오머 형태의 일반식(Ⅰ)화합물, 및 그의 산부가염을 제조하는 방법.
    상기식에서, n은 1 또는 2를 나타내며; R1은 수소, COR2또는 SO2R3를 나타내고; R2는 수소, C1―4알킬 C1―4알콕시 또는 NH―(C1―4알킬)을 나타내며; R3는 C1―4알킬을 나타내고; A는 CHO 또는(여기에서 R′는 H 또는 C1―4알킬을 나타낸다)을 나타내며; R은 가수분해 또는 가수소분해로 제거될 수 있는 보호그룹을 나타내고; R″´는 NH2, NHCOR2, NHSO2R3또는 NO2를 나타내며; R″´는 수소, CH2―아릴, CO―(C1―4알킬) 또는 CO―아릴을 나타내고; RIV는 수소 또는 가수소분해로 제거될 수 있는 그룹을 나타내며, 단 R″´및 RIV중의 적어도 하나는 제거되어야 하는 그룹이다.
  2. 제1항에 있어서, R1이 COR2이고, 여기에서 R2는 제1항에서 정의한 바와 같은 일반식(Ⅰ)의 화합물을 제조하는 방법.
  3. 제1항에 있어서, R1이 SO2R3이고, 여기에서 R3는 제1항에서 정의한 바와 같은 일반식(Ⅰ)의 화합물을 제조하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840004182A 1983-07-18 1984-07-16 1-페닐이미다졸리딘-2-온 유도체의 제조방법 KR850004746A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3325875.9 1983-07-18
DE19833325875 DE3325875A1 (de) 1983-07-18 1983-07-18 Neue 1-phenylimidazolidin-2-on-derivate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
KR850004746A true KR850004746A (ko) 1985-07-27

Family

ID=6204266

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840004182A KR850004746A (ko) 1983-07-18 1984-07-16 1-페닐이미다졸리딘-2-온 유도체의 제조방법

Country Status (20)

Country Link
US (1) US4558061A (ko)
EP (1) EP0131943A3 (ko)
JP (1) JPS6038365A (ko)
KR (1) KR850004746A (ko)
AU (1) AU3079984A (ko)
CS (1) CS244445B2 (ko)
DD (1) DD232695A5 (ko)
DE (1) DE3325875A1 (ko)
DK (1) DK350284A (ko)
ES (3) ES534380A0 (ko)
FI (1) FI842853A (ko)
GB (1) GB2146019B (ko)
GR (1) GR82097B (ko)
HU (1) HUT34957A (ko)
IL (1) IL72421A0 (ko)
NO (1) NO842922L (ko)
PL (1) PL248780A1 (ko)
PT (1) PT78934B (ko)
SU (1) SU1287746A3 (ko)
ZA (1) ZA845491B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19822678A1 (de) * 1998-05-20 1999-11-25 Bayer Ag Substituierte 1,3-Diaza-2-(thi)oxo-cycloalkane

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen

Also Published As

Publication number Publication date
EP0131943A2 (de) 1985-01-23
NO842922L (no) 1985-01-21
EP0131943A3 (de) 1985-03-06
GR82097B (ko) 1984-12-13
CS548584A2 (en) 1985-08-15
PT78934B (de) 1986-10-23
DE3325875A1 (de) 1985-01-31
ZA845491B (en) 1986-03-26
ES8601145A1 (es) 1985-10-16
PL248780A1 (en) 1985-07-16
CS244445B2 (en) 1986-07-17
GB8418266D0 (en) 1984-08-22
US4558061A (en) 1985-12-10
JPS6038365A (ja) 1985-02-27
SU1287746A3 (ru) 1987-01-30
ES8607944A1 (es) 1986-06-01
PT78934A (de) 1984-08-01
AU3079984A (en) 1985-01-24
FI842853A0 (fi) 1984-07-16
DK350284D0 (da) 1984-07-17
ES8603428A1 (es) 1985-12-16
HUT34957A (en) 1985-05-28
IL72421A0 (en) 1984-11-30
DK350284A (da) 1985-01-19
GB2146019A (en) 1985-04-11
FI842853A (fi) 1985-01-19
DD232695A5 (de) 1986-02-05
ES542819A0 (es) 1986-06-01
GB2146019B (en) 1986-11-19
ES534380A0 (es) 1985-10-16
ES542820A0 (es) 1985-12-16

Similar Documents

Publication Publication Date Title
KR860001793A (ko) 벤즈 이미다졸 유도체의 제조방법
KR850004482A (ko) 인돌-3-카르복사미드 유도체의 제조방법
KR850004492A (ko) 옥시캄의 엔올 에테르 유도체의 제조방법
KR840003260A (ko) [(3-아미노-3-카르복시)-프로필-1]포스핀산 유도체의 제조법
KR860001064A (ko) β-락탐 화합물의 제조방법
KR850004754A (ko) 3-인돌 카르복사미드 화합물류의 제조방법
KR850001746A (ko) 퀴나졸린 화합물의 제조방법
KR830005090A (ko) 3,7,11,15-테트라메틸-2,4,6,10,14-헥사데카펜타엔 산(酸)
KR850002459A (ko) 디히드록시벤즈아미드 유도체 및 그 제조방법
KR860001097A (ko) 4-아미노-2-페닐퀴놀린의 제조방법
KR840006206A (ko) 이소퀴놀린 유도체의 제조방법
KR850001724A (ko) 4-페닐-4-옥소-부텐-2-오인산유도체의 제조방법
KR850002460A (ko) 카르바메이트 화합물의 제조방법
KR850004746A (ko) 1-페닐이미다졸리딘-2-온 유도체의 제조방법
KR860003202A (ko) 요오드 트리아미노벤젠 화합물의 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR830005122A (ko) 1-아릴옥시-3-알킬아미노-2-프로판올류의 제조방법
KR840008647A (ko) 대칭 1,4-디하이드로피리딘디카복실 에스테르의 제조방법
KR870004974A (ko) 퀴놀론 카복실산 유도체의 제조방법
KR850007247A (ko) 바이페닐릴설포닐 우레아의 제조방법
KR840006209A (ko) 1,2,3,4-테트라하이드로-1-아미노메틸-4-페닐이소퀴놀린의 제조방법
KR870003093A (ko) 퀴놀론카복실산 유도체의 제조방법
KR850006177A (ko) 신남산 유도체의 제조방법
KR870002118A (ko) 벤질아민 유도체 및 그 제조방법
KR840005136A (ko) 유레아 화합물의 제조방법

Legal Events

Date Code Title Description
WITB Written withdrawal of application